Timothy A. Springer - 18 Mar 2024 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Role: Director, 10%+ Owner
Signature: /s/ Matthew Bartholomae, Attorney-in-Fact for Timothy A. Springer
Issuer symbol: RNAC
Transactions as of: 18 Mar 2024
Net transactions value: +$11,398
Form type: 4
Filing time: 20 Mar 2024, 17:09:02 UTC
Previous filing: 18 Mar 2024
Next filing: 26 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RNAC	Common Stock	Purchase	$11,398	+19,044	+0.06%	$0.5985	31,073,406	18 Mar 2024	See Footnote	F1, F2
holding	RNAC	Common Stock						7,471,625	18 Mar 2024	Direct
holding	RNAC	Common Stock						86,418	18 Mar 2024	By wife

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $0.575 to $0.60. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.